background:   objective: to determine knowledge of hormone therapy (ht), reproductive physiology, and menopause in a population of 40-60 year old women.   materials and methods: this cross-sectional study was conducted through a cluster sampling among 330 women in yazd, islamic republic of iran, in 2010. data was collected using a questionnaire containing questions about reproductive physiology...

More than half of persons living with HIV infection in the United States (U.S.) will be ≥50 years of age by 2020, including postmenopausal women. We conducted a systematic literature review about the effects of (1) HIV infection on age at menopause and (2) menopause on antiretroviral therapy (ART) response, in order to inform optimal treatment strategies for menopausal women living with HIV inf...

BACKGROUND AND METHODOLOGY Late 'age at menopause' is a recognised risk factor for postmenopausal breast cancer and is also associated with decreased use of hormone replacement therapy (HRT). When investigating the association between HRT use and breast cancer risk it is therefore necessary to adjust for the potential confounder, 'age at menopause'. 'Age at menopause', however, cannot be determ...

Introduction: Menopause a critical phase in women life, is defined as last menses and can be declared after 12 months of amenorrhea. Menopause is accompanied by several distressing symptoms that burden patient`s quality of life. Moreover menopause is associated with several cardiovascular and bone complications. Cardiovascular complications are also major cause of mortality among women. Intensi...

Introduction: Although international clinical practice guidelines recognize a continued role for menopausal hormone therapy (HT), particularly symptomatic women <60 years of age or within 10 menopause, safety and tolerability concerns have discouraged HT use due to potential links with perceived increased risk hormone-dependent cancers, an established stroke venous thromboembolism. There is the...

OBJECTIVE To study attitudes toward menopause in women with or at risk of human immunodeficiency virus (HIV) aged 35 to 60 in New York City, NY, USA. DESIGN Data were obtained at the baseline interview in a cohort study of menopause. Of 502 participating women, 92 were postmenopausal and 162 were perimenopausal. RESULTS Overall, 37.5% of women had a relatively favorable attitude toward meno...

Background: Significant changes in scalp, facial and body hair occur after the menopause. These can have a significant negative impact on self-esteem and are also potential markers of endocrine or metabolic diseases. Knowledge of postmenopausal hair changes is important for clinicians to distinguish between normal physiological change and those that require further medical investigation. Object...

OBJECTIVES Women reaching menopause must make a controversial decision about whether to use hormone therapy (HT). The theory of planned behaviour (TPB) was the organizing framework. The objectives were to determine if (1) influence of different TPB constructs varied with stage of menopause and HT use, (2) women with diabetes were influenced in significantly different ways from women without, (3...

Moron et al.: Genome Medicine 2009, 1:76 Abstract The age at natural menopause shows great variability. It has been proposed that early age at menopause is a risk factor for osteoporosis and cardiovascular disease, whereas later age at menopause is a risk factor for breast cancer. In addition, it is thought that the genetic factors accounting for the genetic variability in age at menopause coul...